In inflammatory pathologies of the respiratory systemthere is a change in the rheological characteristics of sputum (increase in viscosity), an increase in its production. For the treatment of respiratory diseases, expectorants and mucolytic agents are prescribed. These drugs dilute sputum, reduce its adhesive properties and accelerate excretion. All medicines used for therapy are divided into several groups.
In this category there are drugs based onplant components (licorice, althaea and others) and possessing resorptive activity (iodides, for example). These agents increase the amount of sputum. It should be noted that the effect of these drugs is quite short. In connection with this, the medication is taken every 2-3 hours. Increased dosages provoke side effects in the form of nausea before vomiting. The shortcomings of the use of these medicines include, in some cases, the formation of too much mucus. Little children are sometimes unable to cough up so many. As a result, the drainage functions of the lungs are significantly impaired, and reinfection occurs.
These drugs are in most cases optimal in the appointment of therapy for respiratory diseases.
This medication is considered one of the most active.Its action is based on reducing the viscosity of mucus, diluting and facilitating its transport from the bronchi. The preparation, in addition, has antitoxic and antioxidant activity. Many mucolytic agents have a similar effect. However, the drug "Acetylcysteine" is characterized by faster and more pronounced activity. The drug is also used as an antidote for overdose with paracetamol. The spectrum of indications of the remedy, in general, is quite wide. In particular, the drug is recommended for intratracheal anesthesia to prevent complications. The effectiveness of the drug is manifested with oral, parenteral, endobronchial and combined use.
